Dopamine and transforming growth factor-1: An odd couple in growth inhibition of the lactotrophs

Endocrinology

Volumn 146, Issue 10, 2005, Pages 4177-4178

  Ben Jonathan, Nira ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; EPIDERMAL GROWTH FACTOR; GALANIN; ISOPROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VOLTAGE GATED CALCIUM CHANNEL;

AUTOCRINE EFFECT; CALCIUM CELL LEVEL; CARCINOGENESIS; CELL FUNCTION; CELL PROLIFERATION; DOWN REGULATION; EPITHELIUM CELL; ESTROGEN ACTIVITY; ESTROGEN THERAPY; GENE DELETION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SWITCHING; GROWTH INHIBITION; HOMEOSTASIS; HORMONAL REGULATION; HORMONE INHIBITION; HUMAN; HYPERPOLARIZATION; MITOSIS INHIBITION; NONHUMAN; PARACRINE SIGNALING; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROLACTIN SECRETING CELL; PROLACTINOMA; PROTEIN PROTEIN INTERACTION; RNA SPLICING; SEX DIFFERENCE; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIVISION; DOPAMINE; GROWTH INHIBITORS; HYPOTHALAMIC HORMONES; RATS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 24944501256     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2005-0893     Document Type: Short Survey

References (21)

1. Ben-Jonathan N, Hnasko RM 2001 Dopamine as a prolactin inhibitor. Endocr Rev 22:724-763
2. Molitch ME 2001 Prolactinomas. In: Horseman ND, ed. Prolactin. Boston: Kluwer; 81-100
3. Webster J 1999 Clinical management of prolactinomas. Baillieres Best Pract Res Clin Endocrinol Metab 13:395-408
4. Cronin MJ, Faure N, Martial JA, Weiner RI 1980 Absence of high affinity dopamine receptors in GH3 cells: a prolactin-secreting clone resistant to the inhibitory action of dopamine. Endocrinology 106:718-723
5. Sarkar DK, Chaturvedi K, Oomizu S, Boyadjieva NI, Chen CP 2005 Dopamine, dopamine D2 receptor short isoform, transforming growth factor-1, and transforming growth factor type II receptor interact to inhibit the growth of pituitary lactotrophs. Endocrinology 146:4179-4189
6. Gregerson KA 2001 Mechanism of dopamine action on the lactotrophs. In: Horseman ND, ed. Prolactin. Boston: Kluwer; 45-61
7. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG 1998 Dopamine receptors: from structure to function. Physiol Rev 78:189-225
8. 2 dopamine receptor messenger ribonucleic acid is modulated by activated sex steroid receptors in the MMQ prolactin cell line. Endocrinology 139:4213-4221
9. Iaccarino C, Samad TA, Mathis C, Kercret H, Picetti R, Borrelli E 2002 Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs. Proc Natl Acad Sci USA 99:14530-14535
10. Ben-Jonathan N, Liu JW 1992 Pituitary lactotrophs: endocrine, paracrine, juxtacrine, and autocrine interactions. Trends Endocrinol Metab 3:254-258
11. Denef C 2003 Paracrine control of lactotrope proliferation and differentiation. Trends Endocrinol Metab 14:188-195
12. Hentges S, Pastorcic M, De A, Boyadjieva N, Sarkar DK 2000 Opposing actions of two transforming growth factor-isoforms on pituitary lactotropic cell proliferation. Endocrinology 141:1528-1535
13. Shi Y, Massague J 2003 Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685-700
14. Govinden R, Bhoola KD 2003 Genealogy, expression, and cellular function of transforming growth factor-β. Pharmacol Ther 98:257-265
15. Bachman KE, Park BH 2005 Duel nature of TGF-β signaling: tumor suppressor vs. tumor promoter. Curr Opin Oncol 17:49-54
16. Scully KM, Gleiberman AS, Lindzey J, Lubahn DB, Korach KS, Rosenfeld MG 1997 Role of estrogen receptor-α in the anterior pituitary gland. Mol Endocrinol 11:674-681
17. Lee EJ, Duan WR, Jakacka M, Gehm BD, Jameson JL 2001 Dominant negative ER induces apoptosis in GH4 pituitary lactotrope cells and inhibits tumor growth in nude mice. Endocrinology 142:3756-3763
18. Kelly MA, Rubinstein M, Asa SL, Zheng G, Saez C, Bunzow JR, Allen R, Hnasko RM, Ben-Jonathan N, Grandy DK, Low MJ 1997 Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19:103-113
19. Shida N, Ikeda H, Yoshimoto T, Oshima M, Taketo MM, Miyoshi I 1998 Estrogen-induced tumorigenesis in the pituitary gland of TGF-(+/-) knockout mice. Biochim Biophys Acta 1407:79-83
20. De A, Hentges S, Boyadjieva N, Sarkar DK 2001 Effect of antisense suppression of transforming growth factor-β3 gene on lactotropic cell proliferation. J Neuroendocrinol 13:324-327
21. Hentges S, Sarkar DK 2001 Transforming growth factor-β regulation of estradiol-induced prolactinomas. Front Neuroendocrinol 22:340-363